INVOLVEMENT OF CYTOKINES IN DETERMINING RESISTANCE AND ACQUIRED-IMMUNITY IN MURINE TUBERCULOSIS

被引:81
作者
DENIS, M
机构
[1] Unite de Recherche, Centre de Pneumologie, Hopital Laval, Ste-Foy, Que. G1V 4G5
关键词
MYCOBACTERIUM-TUBERCULOSIS; MACROPHAGES; MODULATION;
D O I
10.1002/jlb.50.5.495
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Herein we demonstrate that continuous infusion of either TNF-alpha or IFN-gamma (10(4) U/day) via osmotic micropumps leads to an increased resistance of mice infected with a lethal dose (10(7)) of M. tuberculosis H37Rv, associated with a decreased microbial growth in all target organs. This result was reinforced by the finding that infusion of antibodies against TNF-alpha or IFN-gamma greatly enhanced susceptibility of naive mice to tuberculosis. In a final set of experiments, using neutralizing antibodies, we show that IFN-gamma, not TNF-alpha is involved in determining acquired resistance against murine tuberculosis, as seen by the fact that acquired immunity is resistant to anti-TNF-alpha antibodies, yet sensitive to anti-IFN-gamma antibodies. This suggests a role for both IFN-gamma and TNF-alpha in determining innate resistance whereas IFN-gamma may be the mediator of the anamnestic response.
引用
收藏
页码:495 / 501
页数:7
相关论文
共 33 条
[1]  
BANCROFT GJ, 1989, J IMMUNOL, V143, P127
[2]   THE EFFECT OF GAMMA-INTERFERON DURING MYCOBACTERIUM BOVIS (BCG) INFECTION IN ATHYMIC AND EUTHYMIC MICE [J].
BANERJEE, DK ;
SHARP, AK ;
LOWRIE, DB .
MICROBIAL PATHOGENESIS, 1986, 1 (02) :221-224
[3]  
BELOSEVIC M, 1989, J IMMUNOL, V142, P2052
[4]  
BERMUDEZ LEM, 1989, J IMMUNOL, V143, P2996
[5]   REQUIREMENT OF ENDOGENOUS INTERFERON-GAMMA PRODUCTION FOR RESOLUTION OF LISTERIA-MONOCYTOGENES INFECTION [J].
BUCHMEIER, NA ;
SCHREIBER, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) :7404-7408
[6]   INTRACELLULAR KILLING OF MYCOBACTERIA [J].
CROWLE, AJ .
RESEARCH IN MICROBIOLOGY, 1990, 141 (02) :231-236
[7]  
DANNENBERG AJ, 1989, REV INFECT DIS, V11, P5369
[8]  
DOUVAS GS, 1985, INFECT IMMUN, V50, P1
[9]  
EDWARDS CK, 1986, J IMMUNOL, V136, P1820
[10]  
ELLNER JJ, 1978, J IMMUNOL, V121, P2573